Outpace Bio Overview

  • Founded
  • 2020
Founded
  • Status
  • Private
  • Employees
  • 24
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $30M
Latest Deal Amount
  • Investors
  • 10

Outpace Bio General Information

Description

Developer of mechanism-driven solutions intended to improve the safety and efficacy of cell and gene therapies. The company's versatile platform combines the design of improved biological functions with powerful cellular control modalities, harnessing the full complexity of cellular biology to tackle the incurable disease, thereby collaborating with industry leaders by incorporating their insights to create new smart therapies using protein design and synthetic biology.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 500 Fairview Avenue North
  • Suite 560
  • Seattle, WA 98109
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Outpace Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 03-Feb-2021 $30M 0000 00000 Completed Startup
To view Outpace Bio’s complete valuation and funding history, request access »

Outpace Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Outpace Bio’s complete cap table history, request access »

Outpace Bio Executive Team (2)

Name Title Board Seat Contact Info
Marc Lajoie Co-Founder, Chief Executive Officer & Board Member
Scott Boyken Ph.D Co-Founder, Chief Scientific Officer & Board Member
To view Outpace Bio’s complete executive team members history, request access »

Outpace Bio Board Members (3)

Name Representing Role Since
Marc Lajoie Outpace Bio Co-Founder, Chief Executive Officer & Board Member 000 0000
Scott Boyken Ph.D Outpace Bio Co-Founder, Chief Scientific Officer & Board Member 000 0000
Vasudev Bailey Ph.D Self Board Member 000 0000
To view Outpace Bio’s complete board members history, request access »

Outpace Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Outpace Bio Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Abstract Ventures Venture Capital Minority 000 0000 000000 0
ARTIS Ventures Venture Capital Minority 000 0000 000000 0
Breton Capital Ventures Venture Capital Minority 000 0000 000000 0
Civilization Ventures Venture Capital Minority 000 0000 000000 0
Lyell Corporation Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »